Commit To Buy Catalyst Pharmaceuticals At $2.50, Earn 13.8% Annualized Using Options
February 21, 2018 at 11:45 AM EST
Investors eyeing a purchase of Catalyst Pharmaceuticals Inc (CPRX) shares, but tentative about paying the going market price of $3.28/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $2.50 strike, which has a bid at the time of this writing of 20 cents..